Osteoimmunology in Bone Healing Dynamics

Osteoimmunology examines the bidirectional interactions between the immune and skeletal systems, focusing on how immune cells and mediators influence bone repair. Fracture healing unfolds through overlapping phases: an initial inflammatory response, soft callus formation, hard callus formation and remodelling. During the inflammatory phase, innate immune cells such as macrophages clear debris and secrete cytokines that recruit mesenchymal stem cells (MSCs). In the reparative phase, MSCs differentiate into chondrocytes and osteoblasts under the influence of cytokine networks including interleukin-17 (IL-17) and tumour necrosis factor-α (TNFα). Adaptive immune cells, notably Th17 and γδ T cells, further modulate osteogenesis via IL-17A and IL-17F, regulating osteoblast proliferation and function. Osteal macrophages fine-tune osteoclast activity to coordinate matrix deposition and resorption during callus maturation. Factors such as age, sex and microbiome composition influence these cellular crosstalks, with clinical implications for addressing non-union fractures and delayed healing in chronic inflammatory states. Insights from osteoimmunology are paving the way for therapies that manipulate immune responses—through cytokine modulation, microbiome interventions or biomaterial design—to optimise bone regeneration and restore skeletal integrity.

Research from Nature Portfolio

Recent studies have demonstrated that IL-17A produced by γδ T cells is essential for efficient osteogenesis, accelerating callus formation by stimulating mesenchymal progenitor proliferation and osteoblastic differentiation. Mice deficient in IL-17A exhibit impaired bone deposition and delayed mechanical recovery after fracture, establishing a direct immunological control over the osteogenic phase of repair.

Osteoimmunology in Bone Healing Dynamics publication trend

The graph below shows the total number of articles in osteoimmunology in bone healing dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Osteoblast: Bone-forming cell responsible for matrix synthesis and mineralisation.

Osteoclast: Multinucleated cell that resorbs bone matrix during remodelling.

Mesenchymal stem cell (MSC): Multipotent progenitor that differentiates into osteoblasts, chondrocytes and other lineages.

Cytokine: Small secreted protein that mediates communication and regulation among immune and other cells.

T helper 17 (Th17) cell: Subset of CD4+ T cell producing interleukin-17, involved in inflammation and tissue repair.

γδ T cell: Innate-like lymphocyte expressing γδ T-cell receptors, capable of rapid cytokine release.

Callus: Temporary cartilage and bone structure that bridges a fracture during healing.

References

1. Callus γδ T cells and microbial-induced intestinal Th17 cells improve fracture healing in mice. Journal of Clinical Investigation (2023).
2. Emilin2 marks the target region for mesenchymal cell accumulation in bone regeneration. Inflammation and Regeneration (2024).
3. IL-17RA Signaling in Prx1+ Mesenchymal Cells Influences Fracture Healing in Mice. International Journal of Molecular Sciences (2024).
4. IL-17-producing γδ T cells enhance bone regeneration. Nature Communications (2016).
5. T-Lymphocytes Enable Osteoblast Maturation via IL-17F during the Early Phase of Fracture Repair. PLOS ONE (2012).
6. Osteoimmunology of Fracture Healing. Current Osteoporosis Reports (2024).